Roivant Sciences ROIV
NASDAQ ROIV
$41.69 +0.50 (+1.21%)
As of: Nov 11, 2026 · 11:16 AM EST

Roivant Sciences (ROIV) Net Equity Issued and Repurchased (2020 - 2026)

Updated

Roivant Sciences (ROIV) recorded Net Equity Issued and Repurchased of $76.02 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), up 152.9% from $30.06 million a year earlier and up 48.5% from the prior quarter.

Analysis

Roivant Sciences (ROIV) Net Equity Issued and Repurchased (2020 - 2026) Analysis & Trends

On a TTM basis, Roivant Sciences' Net Equity Issued and Repurchased came in at $314.31 million as of Jun 30, 2026, up 306.2% year-over-year; for FY2026 (ended Mar 31, 2026), it was $268.35 million, up 441.1% from FY2025.

  • Annual Net Equity Issued and Repurchased has a four-year compound annual growth rate of 405.2% (FY2022 to FY2026).
  • Across earlier fiscal years, Net Equity Issued and Repurchased came in at $49.6 million in FY2025 (-75.2%), $199.82 million in FY2024 (-36.0%), $311.98 million in FY2023 and $412,000 in FY2022.
  • Quarterly Net Equity Issued and Repurchased has ranged from $412,000 in fiscal Q4 2022 to $217.25 million in fiscal Q4 2023 over the past five years.
  • On a year-over-year basis, Net Equity Issued and Repurchased has increased for four consecutive quarters, with growth averaging 323.5% over the last five quarters.
  • Per Business Quant, the preceding three fiscal quarters came in at $51.19 million (Q4 2026), $118.81 million (Q3 2026) and $68.29 million (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -377.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -966.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -5.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -406.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -283.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Roivant Sciences 29.81 Bn 13.51 Bn 31.77 Mn -49.05 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -49.05 Mn
Jun 30, 2026 -130.08 Mn
Mar 31, 2026 -60.03 Mn
Dec 31, 2025 119.20 Mn
Sep 30, 2025 69.07 Mn
Jun 30, 2025 -178.24 Mn
Mar 31, 2025 -282.47 Mn
Dec 31, 2024 -215.23 Mn
Sep 30, 2024 -98.79 Mn
Jun 30, 2024 -646.11 Mn
Mar 31, 2024 3.66 Mn
Dec 31, 2023 8.88 Mn
Sep 30, 2023 221.53 Mn
Jun 30, 2023 21.03 Mn
Mar 31, 2023 219.81 Mn
Dec 31, 2022 95.30 Mn
Sep 30, 2022 8.33 Mn
Jun 30, 2022 -8.33 Mn
Mar 31, 2022 2.66 Mn
Sep 30, 2021 311.18 Mn
API Access

Roivant Sciences Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ROIV&period=max&api_key=YOUR_API_KEY